HOTH - Hoth stock jumps on FDA approval of study expansion for HT-001
2024-01-18 09:57:45 ET
More on Hoth Therapeutics
- Hoth stock jumps on positive FDA feedback on drug HT-KIT
- Prothena, BioVie among decliners after Biogen data for new Alzheimer’s therapy
- Seeking Alpha’s Quant Rating on Hoth Therapeutics
- Historical earnings data for Hoth Therapeutics
- Financial information for Hoth Therapeutics
For further details see:
Hoth stock jumps on FDA approval of study expansion for HT-001